Intranasal oxytocin to help with pain after pituitary surgery
Official title: Investigating the Effect of TNX-1900 on Pain Management, Neural and Socio-Emotional Functioning in Patients Undergoing Pituitary Surgery
Run by Yale University · NCT07730294 · Data updated 2026-11-12
This study tests whether intranasal oxytocin can reduce pain after pituitary surgery and improve recovery.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 30 Years to 75 Years |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | Yale University Academic / other |
| Locations | 1 site (New Haven, Connecticut) |
| Status | Recruiting |
| Started | November 2026 |
| Main results expected | November 2028 |
| Study ends | November 2028 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07730294 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 30–75 undergoing pituitary surgery without recent changes in psychotropic medications and without exclusionary medical conditions.
✕Probably not a fit
Patients with seizure history, significant liver or kidney impairment, current pregnancy or recent postpartum period, or prior pituitary surgery may have limited or no benefit and could be excluded for safety.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this Phase 2 trial, adults undergoing pituitary surgery are randomly assigned to low-dose oxytocin, high-dose oxytocin, or placebo for seven days before and after surgery. The study uses a double-blind design to compare pain outcomes, neural measures, and socio-emotional health across groups. Researchers will collect surveys and EEG/ERP data to understand how oxytocin might influence pain processing and emotional aspects of recovery. Safety and tolerability will be monitored throughout the perioperative period.
Why it matters
Potential benefit: If successful, the treatment could provide another option to ease pain and improve recovery after pituitary surgery.
How similar studies have gone: Past studies in other settings have explored oxytocin for pain and emotional processing, with mixed results, making this approach exploratory in pituitary surgery.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: Between 30 to 75 years old. * Consent: Ability to give informed consent. * Language: Proficiency in the English language. * Medical Condition: Diagnosed with a pituitary lesion requiring surgery. * Menopausal Status: Post-menopause for women (at least 1 year since last menstrual period). Exclusion Criteria: * Medication: Individuals on stable doses of psychotropic medication for at least the past six weeks are eligible, excluding those with changes in medication within that timeframe. * Neurological Conditions: A history of seizures, current use of anticonvulsants. * Pregnancy: Currently pregnant, currently lactating, or up to 1-year post partum. * Any history of renal impairment (serum creatinine \>1.2 x ULN) * Any history of hepatic impairment (AST and/or ALT \>2 x ULN) * Surgical History: Any history of previous pituitary surgery procedures * Subjects who require 24-hour coverage with NSAIDs, e.g., arthritis, should not be included in the study. * Any known hypersensitivity to TNX-1900
Where it's running
-
Yale University
New Haven, Connecticut, United States Recruiting
Study contacts
- Principal investigator: S. Bulent Omay, MD — Yale University
- Study coordinator: S. Bulent Omay, MD
- Email: sacit.omay@yale.edu
- Phone: 203-737-6885
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing low blood sodium after pituitary surgery with extra protein or fluid restriction
This study tests whether taking extra dietary protein or temporarily limiting fluids after pituitary surgery helps prevent low blood sodium (hyponatremia) in adults.
-
Pet imaging of sigma1 receptors in healthy adults
This study tests two sigma-1 radiotracers, to see how well they image the brain in healthy adults and how reliably the imaging measurements work.
-
Intradermal Flu Vaccine After All: Watching Immune Response in Skin and Blood
This study tests whether giving the seasonal flu shot into the skin (instead of muscle) changes the immune response in healthy adults, cancer patients about to start immunotherapy, and people with post-acute infection syndromes.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand
This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.
-
Greater Occipital Nerve Blockade for Veterans with Post-Traumatic Headache
This study tests whether injecting tiny amounts of anesthesia into the greater occipital nerve can reduce headache days for veterans with chronic post-traumatic headaches.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.